Cargando…

ALDH1A3: A Marker of Mesenchymal Phenotype in Gliomas Associated with Cell Invasion

Aldehyde dehydrogenases (ALDH) is a family of enzymes including 19 members. For now, ALDH activity had been wildly used as a marker of cancer stem cells (CSCs). But biological functions of relevant isoforms and their clinical applications are still controversial. Here, we investigate the clinical si...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Wenlong, Liu, Yanwei, Hu, Huimin, Huang, Hua, Bao, Zhaoshi, Yang, Pei, Wang, Yinyan, You, Gan, Yan, Wei, Jiang, Tao, Wang, Jiangfei, Zhang, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4648511/ https://www.ncbi.nlm.nih.gov/pubmed/26575197 http://dx.doi.org/10.1371/journal.pone.0142856

Ejemplares similares

ALDH1A3 induces mesenchymal differentiation and serves as a predictor for survival in glioblastoma
por: Li, Guanzhang, et al.
Publicado: (2018)

SOCS3 Promoter Hypermethylation Is a Favorable Prognosticator and a Novel Indicator for G-CIMP-Positive GBM Patients
por: Feng, Ying, et al.
Publicado: (2014)

Isocitrate dehydrogenase 1 (IDH1) mutation-specific microRNA signature predicts favorable prognosis in glioblastoma patients with IDH1 wild type
por: Wang, Zheng, et al.
Publicado: (2013)

MEGF10, a Glioma Survival-Associated Molecular Signature, Predicts IDH Mutation Status
por: Li, Guanzhang, et al.
Publicado: (2018)

MicroRNA expression patterns in the malignant progression of gliomas and a 5-microRNA signature for prognosis
por: Yan, Wei, et al.
Publicado: (2014)

The ALDH Family Contributes to Immunocyte Infiltration, Proliferation and Epithelial-Mesenchymal Transformation in Glioma
por: Wang, Zeyu, et al.
Publicado: (2022)

BMP4, a strong better prognosis predictor, has a subtype preference and cell development association in gliomas
por: Bao, Zhaoshi, et al.
Publicado: (2013)

Identification of IDH-mutant gliomas by a prognostic signature according to gene expression profiling
por: Wang, Qiangwei, et al.
Publicado: (2018)

Significance of miR-196b in Tumor-Related Epilepsy of Patients with Gliomas
por: You, Gan, et al.
Publicado: (2012)

Correlation of IDH1 Mutation with Clinicopathologic Factors and Prognosis in Primary Glioblastoma: A Report of 118 Patients from China
por: Yan, Wei, et al.
Publicado: (2012)

Identifying the Association of Contrast Enhancement with Vascular Endothelia Growth Factor Expression in Anaplastic Gliomas: A Volumetric Magnetic Resonance Imaging Analysis
por: Wang, Yinyan, et al.
Publicado: (2015)

Phosphohistone H3 (pHH3) is a prognostic and epithelial to mesenchymal transition marker in diffuse gliomas
por: Zhu, Ping, et al.
Publicado: (2016)

LRRFIP1, an epigenetically regulated gene, is a prognostic biomarker and predicts malignant phenotypes of glioma
por: Ma, Wenping, et al.
Publicado: (2022)

Cancer stem cell markers ALDH1 and CD44+/CD24– phenotype and their prognosis impact in invasive ductal carcinoma
por: Rabinovich, Iris, et al.
Publicado: (2018)

Radiation combined with temozolomide contraindicated for young adults diagnosed with anaplastic glioma
por: Yang, Pei, et al.
Publicado: (2016)

HDAC4, a prognostic and chromosomal instability marker, refines the predictive value of MGMT promoter methylation
por: Cheng, Wen, et al.
Publicado: (2015)

The stem cell/cancer stem cell marker ALDH1A3 regulates the expression of the survival factor tissue transglutaminase, in mesenchymal glioma stem cells
por: Sullivan, Kelly E., et al.
Publicado: (2017)

Protein Markers Associated with an ALDH Sub-Population in Colorectal Cancer
por: Yang, Rui, et al.
Publicado: (2016)

Identification of a 6-Cytokine Prognostic Signature in Patients with Primary Glioblastoma Harboring M2 Microglia/Macrophage Phenotype Relevance
por: Cai, Jinquan, et al.
Publicado: (2015)

Interplay between PCBP2 and miRNA modulates ARHGDIA expression and function in glioma migration and invasion
por: Lin, Xihua, et al.
Publicado: (2016)

Chinese Glioma Genome Atlas (CGGA): A Comprehensive Resource with Functional Genomic Data from Chinese Glioma Patients
por: Zhao, Zheng, et al.
Publicado: (2021)

Classifying lower grade glioma cases according to whole genome gene expression
por: Chen, Baoshi, et al.
Publicado: (2016)

Evaluation of STAT3 Signaling in ALDH+ and ALDH+/CD44+/CD24− Subpopulations of Breast Cancer Cells
por: Lin, Li, et al.
Publicado: (2013)

SAMD9 Is Relating With M2 Macrophage and Remarkable Malignancy Characters in Low-Grade Glioma
por: Ma, Wenping, et al.
Publicado: (2021)

Tumor-associated monocytes promote mesenchymal transformation through EGFR signaling in glioma
por: Chen, Yiyun, et al.
Publicado: (2023)

Multidimensional analysis of gene expression reveals TGFB1I1-induced EMT contributes to malignant progression of astrocytomas
por: Liu, Yanwei, et al.
Publicado: (2014)

KIF23 is an independent prognostic biomarker in glioma, transcriptionally regulated by TCF-4
por: Sun, Lihua, et al.
Publicado: (2016)

Development of an integrated predictive model for postoperative glioma-related epilepsy using gene-signature and clinical data
por: Li, Lianwang, et al.
Publicado: (2023)

Identification of miRNA-Mediated Core Gene Module for Glioma Patient Prediction by Integrating High-Throughput miRNA, mRNA Expression and Pathway Structure
por: Zhang, Chunlong, et al.
Publicado: (2014)

The EZH2 inhibitor GSK343 suppresses cancer stem-like phenotypes and reverses mesenchymal transition in glioma cells
por: Yu, Tianfu, et al.
Publicado: (2017)

ATRX mRNA expression combined with IDH1/2 mutational status and Ki-67 expression refines the molecular classification of astrocytic tumors: evidence from the whole transcriptome sequencing of 169 samples
por: Cai, Jinquan, et al.
Publicado: (2014)

ALDH Expression in Angiosarcoma of the Lung: A Potential Marker of Aggressiveness?
por: Aramini, Beatrice, et al.
Publicado: (2020)

A Novel TNFSF-Based Signature Predicts the Prognosis and Immunosuppressive Status of Lower-Grade Glioma
por: Tao, Rui, et al.
Publicado: (2022)

EGFRvIII Promotes the Proneural–Mesenchymal Transition of Glioblastoma Multiforme and Reduces Its Sensitivity to Temozolomide by Regulating the NF-κB/ALDH1A3 Axis
por: Shi, Zhong-Fang, et al.
Publicado: (2023)

Phenotypic and Expressional Heterogeneity in the Invasive Glioma Cells()()
por: Fayzullin, Artem, et al.
Publicado: (2018)

Comprehensive analysis of the clinical and biological significances of cholesterol metabolism in lower-grade gliomas
por: Tao, Rui, et al.
Publicado: (2023)

HOXC8: a predictive glioma biomarker that induces epithelia-mesenchymal transition
por: Liang, Tingyu, et al.
Publicado: (2018)

ALDH1 as a prognostic marker for lymph node metastasis in OSCC
por: Götz, Carolin, et al.
Publicado: (2018)

Targeting ALDH1A1 by disulfiram/copper complex inhibits non-small cell lung cancer recurrence driven by ALDH-positive cancer stem cells
por: Liu, Xinwei, et al.
Publicado: (2016)

Downregulation of ALDH6A1 is a New Marker of Muscle Insulin Resistance in Type 2 Diabetes Mellitus
por: Liu, Song, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mulgmetuehqj44bh75fpaijpeb